Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327181 · ClinicalTrials.gov registry record · NA
Short Chain Fatty Acid Metabolism in COPD
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT03327181 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 63 participants.
The verdict
NCT03327181, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare the SCFA metabolism in COPD patients to healthy matched controls. This protocol is an extension of recent studies about protein digestion and absorption abnormalities in COPD patients. The investigators hypothesize that SCFA production might be lower in COPD patients than in healthy subjects.
Interventions
- DIETARY_SUPPLEMENT short chain fatty acid tracers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-04-19 |
| Est. Completion | 2019-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327181
The ClinicalTrials.gov registry entry for NCT03327181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which short chain fatty acid tracers is the first listed.
NCT03327181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03327181 about?
NCT03327181 is a clinical study titled "Short Chain Fatty Acid Metabolism in COPD". The short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare the SCFA metabolism in COPD patients to healthy matched controls. This protocol is an extension of recent studies about protein digestion and absorption abnormal...
What is the current status of trial NCT03327181?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2017-04-19. Estimated completion is 2019-02-14.
What interventions are being tested in trial NCT03327181?
The interventions under investigation include: short chain fatty acid tracers (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03327181?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.